PlainPharmaWatch

CMS Open Payments · Program Year 2024

Kansas

Kansas received $33,605,518.69 in pharmaceutical-industry payments to 6,101 physicians and 7 teaching hospitals across 153,471 transactions.

$33.6M
Total payments
$30.5M
To physicians
$810.3K
To teaching hospitals
#27
of 59 states

In CMS Open Payments Program Year 2024, pharmaceutical and medical-device companies reported $33.6M in payments to 6,101 physicians and 7 teaching hospitals in Kansas. That ranks Kansas #27 of 59 states and territories (0.2% of the US total), averaging $5.0K per physician. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

The verdict

Kansas pairs above-median payment volume with an overwhelmingly physician-directed payment mix.

#27
of 59 states
0.2%
of the national total
90.7%
to physicians vs. hospitals
6,101
physicians paid

What the Data Shows for Kansas

Kansas's Open Payments file is physician-weighted: 90.7% of $33.6M went to 6,101 physicians ($5.0K each), with 2.4% on 7 teaching hospitals.

Volume rank is #27 of 59: mid-pack dollars with the mix as the distinctive cut. Average transaction $218.97. Leading nature of payment: "Royalty or License" at $17.6M (52.4% of the state file; top-three natures 78.2%).

Kansas sits in the 56th percentile (lower-volume tier). Just above: Utah ($34.7M). Just below: Louisiana ($33.4M). For context: top-ranked California ($342.4M) is 10.2× larger than Kansas. CMS Sunshine Act framework and methodology.

Physician vs Hospital Payments

How pharmaceutical payments in Kansas are distributed between physicians and teaching hospitals.

Physician Payments

$30.5M

90.7% of total · 6,101 recipients · $5.0K avg

Teaching Hospital Payments

$810.3K

2.4% of total · 7 hospitals · $115.8K avg

Payment Breakdown by Type

Kansas has 16 types of pharmaceutical payments. "Royalty or License" accounts for 52.4%.

Nature concentration in Kansas

Top three Open Payments natures are 78.2% of state dollars; residual is every other reported nature

Royalty or License$17.6MCompensation for Services Ot…$5.2MFood and Beverage$3.4MAll other natures (13)$7.3M

Payment categories in Kansas

Top categories by total reported dollar volume

1. Royalty or License$17.6M2. Compensation for Services…$5.2M3. Food and Beverage$3.4M4. Consulting Fee$3.2M5. Travel and Lodging$1.5M6. Acquisitions$997.3K7. Education$502.0K8. Long-Term Medical Supply …$346.9K9. Grant$214.5K10. Honoraria$204.2K
Payment Type Amount Transactions
Royalty or License $17.6M 38
Compensation for Services Other Than Consulting $5.2M 1,901
Food and Beverage $3.4M 142,738
Consulting Fee $3.2M 1,404
Travel and Lodging $1.5M 5,160
Acquisitions $997.3K 34
Education $502.0K 1,411
Long-Term Medical Supply or Device Loan $346.9K 45
Grant $214.5K 34
Honoraria $204.2K 117
Space Rental or Facility Fees $120.4K 48
Compensation for Faculty or Speaker (Medical Education) $105.0K 56
Gift $61.4K 387
Debt Forgiveness $40.6K 30
Entertainment $5.7K 64
Charitable Contribution $4.9K 4

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Source: CMS Open Payments Database Industry payments to physicians and teaching hospitals · 2024

What Kansas totals can and cannot tell you

The aggregate payment figure for Kansas measures reportable industry–physician engagement inside this state's geographic footprint for Program Year 2024, not any one physician's or hospital's relationship with industry. CMS collects the data under the Physician Payments Sunshine Act; manufacturers must report transfers of value above the de minimis threshold. The file does not capture DTC advertising, internal R&D, wholesale drug pricing, or salary support that is not a reportable transfer of value.

Correlations between payment receipt and prescribing appear in peer-reviewed work for specific drugs and specialties, but this page's state total does not establish causation. Open the company and recipient detail pages for category and year-over-year cuts.

View saved (states)
Download Kansas's data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.